))
Developments in Parkinson's Diagnosis: New Tests, Alpha-Synuclein, and Looking Forward (Part 2)
Manage episode 458685116 series 3632855
内容由Davis Phinney Foundation提供。所有播客内容（包括剧集、图形和播客描述）均由 Davis Phinney Foundation 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Click here to subscribe for our podcast and video content on YouTube.
In this episode, Dr. Arash Fazl discusses the role of the protein alpha-synuclein in Parkinson’s and how this protein is involved in new diagnostic tests for Parkinson’s. Dr. Fazl also shares how these new tests may contribute to additional exciting developments in the future.
This is part two of a two-part series about Parkinson’s diagnosis. In the first episode, Dr. Fazl describes the challenges involved in diagnosing Parkinson’s. This episode picks up in the middle of our conversation with Dr. Fazl, right where we ended the first episode.
This two-part series is sponsored by CND Life sciences, home of the Syn-One Test - the first commercially available skin-based test to help clinicians diagnose Parkinson’s disease and related disorders.
Listen to Part 1 of this podcast series here: https://youtu.be/98AUXc2pgHo
This two-part series is sponsored by CND Life sciences, home of the Syn-One Test - the first commercially available skin-based test to help clinicians diagnose Parkinson’s disease and related disorders.
For more information about the Davis Phinney Foundation visit: https://dpf.org
Season 5 episode 36
100集单集
分享
